FDA official logo
GSRS logo
PFDA official logo

PEGBELFERMIN

  • UNII: P5T1E46W5D
  • Preferred Substance Name: PEGBELFERMIN

  • 2089039-22-3
  • (109-(4-(1-((2-((.OMEGA.-METHOXYPOLY(OXYETHYLENE))FORMAMIDO)ETHOXY)IMINO)ETHYL)-L-PHENYLALANINE))HOMO SAPIENS FIBROBLAST GROWTH FACTOR 21
  • A THERAPEUTIC PEGYLATED FIBROBLAST GROWTH FACTOR 21 AGONIST/MIMETIC WHICH RESTORES LEPTIN RESPONSIVENESS
  • ARX-618
  • BMS-986036
  • L-METHIONYL-(108-(4-(N-(2-((.OMEGA.-METHOXYPOLY(OXYETHYLENE)-.ALPHA.-CARBONYL)AMINO)ETHOXY)ETHANIMIDOYL)-L-PHENYLALANINE) (108Q>X)) HUMAN FIBROBLAST GROWTH FACTOR 21 (FGF21) NATURAL L146>P VARIANT, PRODUCED IN ESCHERICHIA COLI
  • PEGBELFERMIN [INN]
  • PEGBELFERMIN [USAN]
  • PEGBELFERMIN [WHO-DD]
  • PEG-FGF21
  • PEGYLATED-FIBROBLAST GROWTH FACTOR-21
  • POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-HYDRO-.OMEGA.-METHOXY-, 109-ESTER WITH HUMAN FIBROBLAST GROWTH FACTOR 21 (109-(4-(1-((2-(CARBOXYAMINO)ETHOXY)IMINO)ETHYL)-L-PHENYLALANINE))

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.